Option chain shows key data for American Strategic's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for American Strategic.

American Strategic (NYSE:NYC) Stock, Option Chain

American Strategic

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Earnings

Earnings Misses

Large Cap

News

Markets

Analyst Ratings

Trading Ideas

American Strategic Investment Co. (NYSE: NYC) came out with a quarterly loss of $2.84 per share versus the Zacks Consensus Estimate of a loss of $2.99. This compares to loss of $4.77 per share a year ago. These figures are adjusted for non-recurring items.

American Strategic Investment Co. Reports Q2 Loss, Lags Revenue Estimates

Image44

Long Ideas

Insider Trades

Intraday Update

ADVM

APPN

More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying

Movers

ADTN

AGRI

AIRE

AMBC

AORT

ATSG

AUDC

BAND

BLDR

BTBD

BYON

CMND

COKE

CROX

DAVE

DDOG

EVER

FGEN

FWRG

GLDD

GSUN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSDT

JELD

JJSF

JMIA

LCID

MSGM

NUVO

NUWE

PLTN

PLTR

PRGO

REAX

SELF

SGRY

STIM

STRL

TALK

TWKS

ZETA

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

American Strategic Investment Co. Class A Common Stock

American Strategic Investment Co

NewYorkCoin

New York Community Capital Trust V 6 % Bifurcated Option Note Unit Secs Cons of 1 6% Trust Pfd Sec 1.11.51 ' 1 Wt 7.5.51

New York Community Capital Trust V

ABOS

ABSI

ACNT

ACTG

AENT

AGEN

AIOT

AIRG

ALIT

ALTG

AMPS

AMTX

APEI

AREB

ARIS

ARMN

ATRA

AUTL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXSM

AZTA

BHIL

BLDE

BLFS

BLTE

The Beachbody Company, Inc. Class A Common Stock

BODI

BRTX

BTMD

BTTR

BWAY

BXSL

BZFD

CAMT

CART

CATX

CAVA

CBAT

CBLL

CCLD

CGEN

CHGG

CHMI

CLSD

CNNE

CRNX

CRON

CRVS

CRWS

CVAC

CXAI

DAVA

DRCT

DYAI

EARN

EGAN

ELMD

ETON

EVCM

EVGO

EYEN

FENG

FIHL

FLNG

FOUR

FTCI

GENI

GENK

GMGI

GOVX

GRAL

GRDN

GROV

GRPN

GRVY

Earnings Scheduled For November 12, 2024

American Strategic Investment Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyc#NYSE">NYC</a>) came out with a quarterly loss of $2.84 per share versus the Zacks Consensus Estimate of a loss of $2.99. This compares to loss of $4.77 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.02%. A quarter ago, it was expected that this company would post a loss of $3.07 per share when it actually produced a loss of $3.28, delivering a surprise of -6.84%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
American Strategic Investment Co., which belongs to the Zacks Real Estate - Operations industry, posted revenues of $15.75 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 1.92%. This compares to year-ago revenues of $15.78 million. The company has not been able to beat consensus revenue estimates over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
American Strategic Investment Co. Shares have added about 9.7% since the beginning of the year versus the S&amp;P 500&#39;s gain of 11.5%.
<h2>What&#39;s Next for American Strategic Investment Co.</h2>
While American Strategic Investment Co. Has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for American Strategic Investment Co. Mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$3 on $16.2 million in revenues for the coming quarter and -$12.32 on $64.05 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Real Estate - Operations is currently in the bottom 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
UBS (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ubs#NYSE">UBS</a>), another stock in the broader Zacks Finance sector, has yet to report results for the quarter ended June 2024. The results are expected to be released on August 14.
This bank is expected to post quarterly earnings of $0.12 per share in its upcoming report, which represents a year-over-year change of -93.6%. The consensus EPS estimate for the quarter has been revised 24% lower over the last 30 days to the current level.
UBS&#39;s revenues are expected to be $11.42 billion, up 19.7% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2319783/american-strategic-investment-co-nyc-reports-q2-loss-lags-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2319783">To read this article on Zacks.com click here.</a>

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(2.99) by 5.02 percent. This is a 283.78 percent decrease over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $15.75 million which missed the analyst consensus estimate of $16.06 million by 1.91 percent. This is a 0.18 percent decrease over sales of $15.78 million the same period last year.

Earnings Beats

American Strategic Q2 Adj $(2.84) Beats $(2.99) Estimate, Sales $15.75M Miss $16.06M Estimate

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Adverum Biotechnologies</h3>
<ul>
<li>The Trade: Adverum Biotechnologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) 10% owner Braden Michael Leonard <a href="https://www.benzinga.com/quote/ADVM/analyst-ratings">acquired a total of 216,264 shares</a> at an average price of $8.26. To acquire these shares, it cost around $1.79 million.</li>
<li>What's Happening: On July 17, Adverum Biotechnologies released data from its ongoing LUNA Phase 2 trial for Ixo-vec in patients with wet age-related macular degeneration (AMD).</li>
<li>What Adverum Biotechnologies Does: Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company.</li>
</ul>
<h3 class="wp-block-heading">Appian</h3>
<ul>
<li>The Trade: Appian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>) 10% owner Colin T. Moran acquired a total of 300,000 shares at &lt;/em&gt;&lt;/a&gt; an average price of $35.40. To acquire these shares, it cost around $10.6 million.</li>
<li>What's Happening: Appian will release financial results for the second quarter, before the opening bell on Thursday, Aug. 1.</li>
<li>What Appian Does: Appian is a low-code enterprise platform-as-a-service company focusing on business process management.</li>
</ul>
<h3 class="wp-block-heading">American Strategic Investment</h3>
<ul>
<li>The Trade: American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) 10% owner New York City Advisors, LLC <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 125,864 shares</a> at an average price of $10.98. To acquire these shares, it cost around $1.38 million.</li>
<li>What's Happening: On May 10, the company posted downbeat quarterly sales.</li>
<li>What American Strategic Investment Does: American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39859847/netflix-to-rally-more-than-10-here-are-10-top-analyst-forecasts-for-friday">Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday</a></li>
</ul>

$11.00 Offer Represents $0.75 Per Share Increase in Offer Price to May 7, 2024 Tender Offer
NEW YORK, June 26, 2024 /PRNewswire/ --&nbsp;Bellevue Capital Partners, LLC ("Bellevue") announced today that it has increased the purchase price of its previously announced tender offer to purchase up to 125,000 shares of American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) ("ASIC") common stock from the previous purchase price of $10.25 to an increased purchase price of $11.00 per share (the "Tender Offer"). The Tender Offer will close on July 5, 2024.

Bellevue Capital Partners Increases The Purchase Price For Its Previously Announced Tender Offer For Shares Of American Strategic Investment From $10.25 To $11 Per Share

Asset Sales

American Strategic Investment Co. Announced That It Has Agreed To A Term Sheet To Sell Its 9 Times Square Midtown Manhattan Property For $63.5M

WIIM

American Strategic Investment shares are trading higher after Bellevue Capital Partners announced it increased its purchase price of its previously announced tender offer for shares of the company.

The Tender Offer will close on&nbsp;July 5, 2024. The $10.25 offer represents $1.00 per share increase in offer price to may 7, 2024 tender offer. 
&nbsp;

Offerings

Bellevue Increases Purchase Price Of Its Previously Announced Tender Offer To Purchase Up To 125K Shares Of American Strategic Investment Common Stock From $9.25 To $10.25 Per Share

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(3.28) per share. This is a 43.15 percent increase over losses of $(5.77) per share from the same period last year. The company reported quarterly sales of $15.481 million which missed the analyst consensus estimate of $15.782 million by 1.91 percent. This is a 0.34 percent decrease over sales of $15.534 million the same period last year.

American Strategic Q1 2024 GAAP EPS $(3.28) Up From $(5.77) YoY, Sales $15.481M Miss $15.782M Estimate

Shares of Beyond, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) fell sharply during Tuesday&#8217;s session following weaker-than-expected <a href="https://www.benzinga.com/quote/BYON">quarterly results</a>.
Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. The company&#8217;s sales came in at $382.281 million versus estimates of $389.264 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Beyond shares dipped 20.8% to $17.34 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Golden Sun Health Technology Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) shares gained 94.7% to $5.60. Golden Sun Health Technology Group regained compliance with Nasdaq continued listing requirement.</li>
<li>MMTec, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) gained 79.1% to $4.1189.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares climbed 50.5% to $0.2572 after the company posted a narrower-than-expected quarterly loss.</li>
<li>Great Lakes Dredge &amp; Dock Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLDD#NASDAQ">GLDD</a>) rose 31.5% to $9.26 following better-than-expected first-quarter financial results.</li>
<li>American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) jumped 29.6% to $7.52.</li>
<li>Motorsport Games Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) gained 29.2% to $2.9493. Motorsport Games is expected to report its financial results for the first quarter of 2024 on Tuesday, May 7.</li>
<li>FibroGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) surged 28.7% to $1.4899 after the company reported mixed first quarter financial results.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) rose 26.7% to $5.07 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) gained 25.1% to $1.0699 after the company announced the completion of its previously announced acquisition of Naamche.</li>
<li>Dave Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NYSE">DAVE</a>) gained 25% to $58.20 after the company reported better-than-expected first-quarter financial results and issued FY24 operating revenue.</li>
<li>Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) surged 24.8% to $1.46 after the company signed an exclusive patent licensing agreement with Yissum Research Development Company.</li>
<li>Thoughtworks Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWKS#NASDAQ">TWKS</a>) jumped 22% to $3.0750 after the company issued strong guidance.</li>
<li>The Real Brokerage Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) gained 21.5% to $5.07 following strong quarterly sales.</li>
<li>Global Self Storage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SELF#NASDAQ">SELF</a>) rose 21.2% to $5.05.</li>
<li>Zeta Global Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NASDAQ">ZETA</a>) rose 21% to $15.72 after the company reported better-than-expected first-quarter financial results and increased its second-quarter revenue guidance.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) climbed 19.3% to $6.53 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Bandwidth Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAND#NASDAQ">BAND</a>) gained 19.2% to $24.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>ADTRAN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) climbed 18.4% to $5.58 following upbeat quarterly results.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) gained 18.3% to $6.47 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Ambac Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBC#NYSE">AMBC</a>) shares rose 16.5% to $17.64 following better-than-expected first-quarter earnings.</li>
<li>FibroGen, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) gained 15.5% to $1.34 after the company reported mixed first-quarter financial results.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) rose 15.1% to $121.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>Coca-Cola Consolidated, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) jumped 14.5% to $981.96 following first-quarter results.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) gained 14% to $215.29 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance above estimates.</li>
<li>J&amp;J Snack Foods Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) gained 13.5% to $156.51 following better-than-expected quarterly results.</li>
<li>Artivion, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) gained 13.4% to $23.90 following strong quarterly results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) gained 12.7% to $24.09 after the company reported better-than-expected first quarter financial results and issued second quarter revenue guidance above estimates.</li>
<li>Air Transport Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATSG#NASDAQ">ATSG</a>) rose 12.7% to $14.94 following upbeat earnings.</li>
<li>Surgery Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) gained 9.3% to $27.98 following upbeat earnings.</li>
<li>Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) climbed 8.6% to $137.52 following first quarter financial results.</li>
<li>Symbotic Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NYSE">SYM</a>) shares rose 8.1% to $45.33 after the company reported mixed second-quarter financial results.</li>
<li>UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) shares gained 8% to $29.81 after the company posted better-than-expected results for its first quarter.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares gained 6.9% to $12.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Holdco Nuvo Group D.G Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVO#NASDAQ">NUVO</a>) fell 39.2% to $3.1999 after jumping 157% on Monday.</li>
<li>The Real Good Food Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGF#NASDAQ">RGF</a>) dipped 32.6% to $0.5312.</li>
<li>Neuronetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) fell 32.5% to $2.5281 following quarterly results.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRI#NASDAQ">AGRI</a>) shares fell 27.4% to $0.1048 after the company announced an offering of 432.5 million shares by selling stockholders.</li>
<li>Strong Global Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGE#NYSE">SGE</a>) fell 27.4% to $1.9201. Fundamental Global announced acquisition of Strong/MDI Screen Systems, Inc. by FG Acquisition Corp. at a $30 million valuation.</li>
<li>GreenPower Motor Company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GP#NASDAQ">GP</a>) shares declined 25.6% to $1.35 after the company reported pricing of $2.3 million underwritten public offering.</li>
<li>JELD-WEN Holding, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) fell 23.5% to $14.56 as the company posted downbeat quarterly sales and lowered 2024 revenue guidance.</li>
<li>Oriental Culture Holding LTD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) dipped 22.6% to $1.2001.</li>
<li>BT Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBD#NASDAQ">BTBD</a>) fell 21.4% to $1.25.</li>
<li>Plutonian Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTN#NASDAQ">PLTN</a>) shares fell 19.3% to $11.41 after surging 57% on Monday.</li>
<li>Talkspace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>) fell 18.3% to $2.60 following first-quarter results.</li>
<li>Helius Medical Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares declined 16.2% to $2.03 after the company announced pricing of $6.4 million public offering.</li>
<li>Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) fell 15.5% to $18.76 following first-quarter results.</li>
<li>Myers Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) declined 15.5% to $19.43 following first-quarter results.</li>
<li>Builders FirstSource, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) dipped 15.4% to $170.00 following first-quarter earnings.</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) fell 14.3% to $21.56 following soft revenue guidance.</li>
<li>AudioCodes Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUDC#NASDAQ">AUDC</a>) shares fell 13% to $9.89 after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/AUDC/earnings">first-quarter financial results</a></li>
<li>First Watch Restaurant Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) dipped 12.6% to $21.96 following weak quarterly sales.</li>
<li>Teradata Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) dipped 11.4% to $33.63 after the company reported mixed first-quarter financial results and issued second-quarter guidance.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shares fell 11.2% to $2.71 after the company reported mixed first-quarter financial results.</li>
<li>The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) dipped 9.6% to $105.28 following a second-quarter revenue miss.</li>
<li>Methode Electronics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) fell 9.4% to $11.37. Methode Electronics named Kevin Nystrom as interim CEO, effective immediately.</li>
<li>Datadog, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) fell 8.9% to $115.57 following first-quarter results.</li>
<li>Air Lease Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) dipped 7.8% to $47.49 following weak quarterly sales.</li>
<li>Perrigo Company plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) fell 6.3% to $31.32 following weak quarterly sales.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38670858/dow-surges-over-50-points-disney-earnings-top-views">Dow Surges Over 50 Points; Disney Earnings Top Views</a>

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) (&quot;ASIC&quot; or the &quot;Company&quot;) announced today that it completed one new license agreement in the&nbsp;first quarter&nbsp;for approximately 8,000 square feet, resulting in a portfolio occupancy of&nbsp;87.2%. Additionally, the Company&#39;s leasing pipeline totals approximately 14,000 square feet.

American Strategic Investment Co. Secures New Lease, Boosting Portfolio Occupancy to 87.2%

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.07) by 642.86 percent. This is a 372.73 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $15.38 million which missed the analyst consensus estimate of $16.53 million by 6.96 percent. This is a 5.04 percent decrease over sales of $16.20 million the same period last year.

American Strategic Q4 EPS $(0.52) Misses $(0.07) Estimate, Sales $15.38M Miss $16.53M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
&bull; Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) is expected to report earnings for its fourth quarter.
&bull; Sachem Cap (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SACH#AMEX">SACH</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $16.58 million.
&bull; Enservco (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ENSV#AMEX">ENSV</a>) is projected to report quarterly loss at $0.05 per share on revenue of $6.60 million.
&bull; NexGel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXGL#NASDAQ">NXGL</a>) is likely to report quarterly loss at $0.11 per share on revenue of $1.38 million.
&bull; Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) is likely to report earnings for its fourth quarter.
&bull; SPAR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) is estimated to report earnings for its fourth quarter.
&bull; Escalade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESCA#NASDAQ">ESCA</a>) is estimated to report earnings for its fourth quarter.
&bull; LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) is likely to report quarterly loss at $1.73 per share on revenue of $2.28 million.
&bull; Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) is projected to report earnings for its fourth quarter.
&bull; Crown ElectroKinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) is expected to report earnings for its fourth quarter.
&bull; LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) is estimated to report earnings for its fourth quarter.
&bull; DecisionPoint Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DPSI#AMEX">DPSI</a>) is expected to report earnings for its fourth quarter.
&bull; Edible Garden AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>) is estimated to report earnings for its fourth quarter.
&bull; Laser Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) is expected to report earnings for its fourth quarter.
&bull; Terran Orbital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLAP#NYSE">LLAP</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $32.81 million.
&bull; Sigma Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $105.82 million.
&bull; Vislink Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) is estimated to report earnings for its fourth quarter.
&bull; Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) is projected to report quarterly loss at $0.30 per share on revenue of $2.82 million.
&bull; Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $4.27 million.
&bull; TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) is projected to report quarterly loss at $0.69 per share on revenue of $5.45 million.
&bull; Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) is projected to report quarterly loss at $1.18 per share on revenue of $22.45 million.
<h3>Companies Reporting After The Bell</h3>
&bull; BurgerFi International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) is expected to report quarterly loss at $0.19 per share on revenue of $40.00 million.
&bull; AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) is expected to report earnings for its fourth quarter.
&bull; PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) is expected to report quarterly earnings at $3.53 per share on revenue of $2.42 billion.
&bull; VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $9.37 million.
&bull; Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) is estimated to report earnings for its fourth quarter.
&bull; Yield10 Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) is estimated to report quarterly loss at $0.30 per share on revenue of $30 thousand.
&bull; OMNIQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMQS#NASDAQ">OMQS</a>) is likely to report quarterly loss at $0.26 per share on revenue of $16.35 million.
&bull; FlexShopper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>) is projected to report quarterly loss at $0.25 per share on revenue of $30.51 million.
&bull; Stryve Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAX#NASDAQ">SNAX</a>) is estimated to report quarterly loss at $1.96 per share on revenue of $5.01 million.
&bull; Air Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIRI#AMEX">AIRI</a>) is expected to report quarterly loss at $0.34 per share on revenue of $12.40 million.
&bull; Eastside Distilling (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) is expected to report quarterly loss at $0.90 per share on revenue of $3.68 million.
&bull; BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) is expected to report earnings for its fourth quarter.
&bull; SKYX Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYX#NASDAQ">SKYX</a>) is likely to report quarterly loss at $0.08 per share on revenue of $21.12 million.
&bull; Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) is projected to report earnings for its fourth quarter.
&bull; Natural Gas Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGS#NYSE">NGS</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $30.30 million.
&bull; TOMI Environmental Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) is expected to report quarterly loss at $0.01 per share on revenue of $2.86 million.
&bull; Canoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) is likely to report quarterly loss at $1.77 per share on revenue of $700 thousand.
&bull; GSE Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVP#NASDAQ">GVP</a>) is likely to report quarterly loss at $0.81 per share on revenue of $12.07 million.
&bull; Acorda Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOR#NASDAQ">ACOR</a>) is likely to report earnings for its fourth quarter.
&bull; Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) is projected to report earnings for its fourth quarter.
&bull; SHF Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>) is likely to report earnings for its fourth quarter.
&bull; Ideanomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) is likely to report earnings for its fourth quarter.
&bull; American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $16.53 million.
&bull; Zomedica (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZOM#AMEX">ZOM</a>) is expected to report earnings for its fourth quarter.
&bull; Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $94.43 million.
&bull; Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $50.27 million.
&bull; IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) is projected to report quarterly loss at $0.07 per share on revenue of $10.00 million.
&bull; Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) is expected to report quarterly loss at $0.25 per share on revenue of $3.00 million.
&bull; Pioneer Power Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPSI#NASDAQ">PPSI</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $10.89 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Comments

American Strategic

American Strategic (NYC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga